1. Pat Tille Ph.D. MLS (ASCP) Assistant Dept. Head Chemistry and Biochemistry Program Director Medical Laboratory Science South Dakota State University Education and Healthcare Collaboration: The Next Generation of Professionals

2. Review traditional MLS/MLT models and professional training Explain NAACLS standards and revisions in laboratory science education List the challenges and opportunities to continue to produce high quality laboratory professionals Objectives

3. Laboratory Science Education Hospital Based Programs University Based Programs

4. Hospital Based Programs 12 months Lecture and Laboratory simultaneous Trained for laboratory in house Small Labor intensive Cost prohibitive

5. University Based Programs Historically chemistry degrees Low enrollments Last resort majors Change in pedagogy last 5 years Expensive Not real laboratory experience Length 12 weeks to 9 months

6. Myths Hospital Based Program students score higher on the ASCP exam than University Based students (Evidence) Hospital Based students stay in the field longer (Conjecture) Hospital Based students have more broad training (Conjecture)

7. Content Versus Automation Large instruments Hands on theory Keeping a balance

8. ASCP Board of Certification Average of First Time Individual Student Scaled Scores Overall Pass Rate 100% First Time Pass Rate 92% ✪ ✪ SDSU Program Scores Higher than ✪ Hospital and University Based Program National Averages

9. Overall Professional Program Retention 83.4% Overall Success in Clinical Practice 96.8%*

10. SDSU Sub-content Areas IMMUNOHEME: Consistently added improved laboratory exercises; Fall of 2013 added a second semester. CHEMISTRY: Expanded Instrumentation for implementation this fall. HEMATOLOGY: Expanded differential counts, disease states and laboratory exercises. Implementing Cella-vision proficiency software this fall. URINALYSIS: Continued adding disease correlations; Fall 2013 added phase contrast microscopy.

11. SDSU Sub-Content Areas IMMUNOLOGY; Consistently added more content and techniques including DFA, ANA; 2013 Supporting Course for Advanced Methods: MLS 471 included instrumentation in advanced immunoelectrophoresis and immunofixation MICROBIOLOGY: Consistently added more content; more variety of organisms, anaerobes, DFA, Acid Fast, Fungal Staining, increased gram stain interpretations, expanding micro II lab this fall, increasing antibiotic susceptibility interpretations. GENERAL LAB: 2013 Added more application and review of basic concepts; implementation of LIS. For the class of 2014, expanding instrumentation and quality control exercises

12. NAACLS- Myths Prescriptive Curriculum outlined Rotations, Internships Length

13. New Standards Competency Based- Outcome Measures Benchmarks: Measurable, empirical start points? Must publish one according to NAACLS Guidelines (External certification rates, graduation rates, attrition rates, placement rates, others exit interviews, alumni interviews etc.) Must be a three year aggregate Program Director; MLS ASCP Certified Accreditation: 5 yr Initial, 10 year re-accreditation

14. CHALLENGE Reduction in laboratory professionals Education and Patient Care

15. CHALLENGE Reduction in Clinical Training Sites Lengths of Rotations Staff in Clinical Training Sites; qualifications

16. CHALLENGE University Faculty

17. OPPORTUNITY Create model laboratory professionals Create new models in education

18. OPPORTUNITY MLT  MLS  DCLS Inter-professional advanced practice Professional Growth Opportunities

19. Doctorate in Clinical Lab Science Career ladder Epidemiology Pharmacology Patient Assessment

20. OPPORTUNITY Draw in a wider variety of professionals Maintain laboratory testing personnel

21. Center for Collaborative Education Quality Performance Assessment Aligned to the curriculum Meets or exceeds core standards Deliver Rigorous, culturally responsive and relevant instruction Leadership Development Professional Learning Community

22. The future of healthcare In the future will we even go to the hospital? Yes, but we will spend less time as inpatients and more time being monitored remotely by a team of experts. Prevention will be a higher priority. And if you do become ill, a robot may stand in for your doctor. Drugs of the future will target specific cells. Replacement organs will be a reality within years. Gene therapy will be a part of patient care. How and when will we get to this future?

23. The doctor-patient relationship is evolving: Telemedicine means caregivers are remote, but their care isn’t.

24. New Models, Collaborative Content Design and Review

25. ANSWERS?

26. QUESTIONS AND COMMENTS!